我如何诊断和治疗急性感染相关的紫炎
Pavan K Bendapudi1,2,3,4, Julie-Aurore Losman4,5,6
1Division of Hematology and Blood Transfusion Service, Massachusetts General Hospital, Boston, MA.
Blood
|January 9, 2025
概括
紫色 (PF),严重的败血症并发症,涉及蛋白C通路的失败导致危险的凝血. 早期诊断和有针对性的治疗,如抗凝剂替代,可以改善这种关键条件的结果.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 紫色 (PF) 是一种罕见的,严重的败血症并发症.
- 它涉及分散的血管内凝血 (DIC) 的血栓性亚型.
- 由于患者的病情迅速恶化,PF需要紧急咨询血液学家.
研究的目的:
- 审查PF的临床特征和诊断.
- 描述PF的基于证据的治疗策略.
- 突出在PF管理中避免的干预措施.
主要方法:
- 对现有的关于PF的临床文献的审查.
- 纳入PF病理生理学的最新进展.
- 合理设计的治疗方法的描述.
主要成果:
- PF的特征是抗凝固蛋白C通路的失败.
- 这种失败会导致不受控制的微血管凝固和细胞保护作用的丧失.
- 幸存者经常面临严重的痕和组织损失从血栓形成.
结论:
- PF是一种与败血症相关的DIC的独特,可预测的形式.
- 针对性的治疗可以改善结果,尽管条件的严重程度.
- 关键干预措施包括抗凝剂补充和优化输血支持.
相关概念视频
Peptic Ulcer Disease IV: Management
72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72
Pleural Effusion II: Symptoms and Management
151
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
151
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298


